Evidence map›Paper›PMID 40950037›Full record

ArticlebioRxiv : the preprint server for biology2025

Leveraging learned representations and multitask learning for lysine methylation site discovery.

François Charih, Mullen Boulter, Kyle K Biggar, James R Green

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

François CharihDepartment of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.ORCID 0000-0002-7931-8921
Mullen BoulterInstitute of Biochemistry, Department of Biology, Carleton University, Ottawa, ON, Canada.
Kyle K BiggarInstitute of Biochemistry, Department of Biology, Carleton University, Ottawa, ON, Canada.
James R GreenDepartment of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.ORCID 0000-0002-6039-2355

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lysine methylation is a dynamic and reversible post-translational modification of proteins carried out by lysine methyltransferase enzymes. The role of this modification in epigenetics and gene regulation is relatively well understood, but our understanding of the extent and the role of lysine methylation of non-histone substrates remains fairly limited. Several lysine methyltransferases which methylate non-histone substrates are overexpressed in a number of cancers and are believed to be key drivers of cancer progression. There is great incentive to identify the lysine methylome, as this is a key step in identifying drug targets. While numerous computational models have been developed in the last decade to identify novel lysine methylation sites, the accuracy of these model has been modest, leaving much room for improvement. In this work, we leverage the most recent advancements in deep learning and present a transformer-based model for lysine methylation site prediction which achieves state-of-the-art accuracy. In addition, we show that other post-translational modifications of lysine are informative and that multitask learning is an effective way to integrate this prior knowledge into our lysine methylation site predictor, MethylSight 2.0. Finally, we validate our model by means of mass spectrometry experiments and identify 68 novel lysine methylation sites. This work constitutes another contribution towards the completion of a comprehensive map of the lysine methylome.

Indexed as

deep learningLysine methylationlysine methylomemultitask learningtransformers

Identifiers

PMID40950037
PMCPMC12424735

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.